Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04498884Completed
Randomised, double-blind trial of Insulin human regular + insulin isophane in diabetes mellitus (DM) (2 arms), sponsored by Geropharm. Primary endpoints: Area Under the Curve 0-12 hours, Maximum Concentration and 5 more. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04498884.